Vagisten-v Cream
Product Images NDC 69729-612

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vagisten-v (NDC 69729-612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opmx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0-uc_vagisten-v Crema 2pct_back (0 Uc Vagisten V Crema 2pct Back)

This is a drug fact sheet for a medication containing 2% miconazole nitrate in a cream form. It is to be used for the treatment of vaginal yeast infections, external itching and irritation, and is applied via an applicator. The user is advised to ask a doctor before use if she has never had a yeast infection diagnosed, if experiencing new symptoms, if experiencing serious symptoms or if taking prescription blood thinning medication. It also warns not to use if there are punctures on the tube opening, to avoid using other vaginal products, and store at 20°-25°C.*

FDA Label Image

0-uc_vagisten-v Crema 2pct_front (0 Uc Vagisten V Crema 2pct Front)

This is a description of Vagisten-V, an antifungal vaginal cream that contains 2% of miconazole nitrate in a dose of 100mg per applicator. It is intended to cure vaginal yeast infections and relieve associated external itching and irritation. The net weight of the cream is noted, as is the fact that it is an effective treatment against vaginal infections. It is distributed exclusively by Innovarix Farmaceutique and the company is located in San Diego, California.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.